Specializing in innovative medical devices for the treatment of atrial fibrillation and related conditions, this company is a key player in the cardiac surgical ablation market. Investors monitor its growth potential in electrophysiology and minimally invasive surgical tools.
2 members of Congress have disclosed 11 trades in AtriCure, Inc. (ATRC), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-05-06 | Gilbert Cisneros | buy | $1K – $15K |
| 2024-07-19 | Josh Gottheimer | buy | $1K – $15K |
| 2024-06-18 | Josh Gottheimer | sell | $1K – $15K |
| 2021-06-08 | Josh Gottheimer | sell | $1K – $15K |
| 2020-04-30 | Gilbert Cisneros | sell | $1K – $15K |
| 2020-03-31 | Gilbert Cisneros | buy | $1K – $15K |
| 2020-02-21 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-11-07 | Gilbert Cisneros | buy | $1K – $15K |
| 2019-06-27 | Gilbert Cisneros | buy | $1K – $15K |
| 2019-05-08 | Gilbert Cisneros | buy | $1K – $15K |